Exascale Labs Reports FY GAAP EPS Loss and Revenue Growth
Exascale Labs Holdings Inc. reported a fiscal year (FY) loss of $8,108.26 per share under Generally Accepted Accounting Principles (GAAP), despite achieving revenue growth to $14.8 million in the period, representing an increase of 111.4% compared to the previous year. As of June 30, 2026, Exascale held $2.7 million in cash. The company later closed a business combination on August 27, 2026, which is expected to provide additional financial resources and strategic direction for future operations. The significant GAAP loss reflects the challenges faced by the firm during its fiscal year but was offset by strong revenue performance driven by market demand or operational improvements.
Tickers: $XLAB
Topics: Cash Position Earnings Revenue Growth